abstract |
The present invention relates to the discovery that certain DPP-4 inhibitors are particularly suitable for treating and / or preventing metabolic diseases, in particular diabetes, in patients with insufficient glycemic control to go from therapy with an oral antidiabetic drug and / or not oral. |